These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 28766115)

  • 1. Is There a Role for Preoperative 5 Alpha Reductase Inhibitors in Reducing Prostate Vascularity and Blood Loss?
    Bruha M; Welliver C
    Curr Urol Rep; 2017 Oct; 18(10):75. PubMed ID: 28766115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transurethral Resection of Prostate and Bleeding: A Prospective, Randomized, Double-Blind Placebo-Controlled Trial to See the Efficacy of Short-Term Use of Finasteride and Dutasteride on Operative Blood Loss and Prostatic Microvessel Density.
    Bansal A; Arora A
    J Endourol; 2017 Sep; 31(9):910-917. PubMed ID: 28650680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rates of prostate surgery and acute urinary retention for benign prostatic hyperplasia in men treated with dutasteride or finasteride.
    Kuiper JG; Bezemer ID; Driessen MT; Vasylyev A; Roehrborn CG; Penning-van Beest FJ; Herings RM
    BMC Urol; 2016 Aug; 16(1):53. PubMed ID: 27580700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing Clinical and Economic Outcomes Associated with Early Initiation of Combination Therapy of an Alpha Blocker and Dutasteride or Finasteride in Men with Benign Prostatic Hyperplasia in the United States.
    DerSarkissian M; Xiao Y; Duh MS; Lefebvre P; Swensen AR; Bell CF
    J Manag Care Spec Pharm; 2016 Oct; 22(10):1204-14. PubMed ID: 27668569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Pharmacological Treatment for Male LUTS due to BPH: Dutasteride or Finasteride?
    Pirozzi L; Sountoulides P; Castellan P; Presicce F; Lombardo R; Romero M; De Nunzio C; Tubaro A; Schips L; Cindolo L
    Curr Drug Targets; 2015; 16(11):1165-71. PubMed ID: 25981606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review of the effects and mechanisms of preoperative 5α-reductase inhibitors on intraoperative haemorrhage during surgery for benign prostatic hyperplasia.
    Zong HT; Peng XX; Yang CC; Zhang Y
    Asian J Androl; 2011 Nov; 13(6):812-8. PubMed ID: 21892196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of preoperative 5α-reductase inhibitors on perioperative blood loss in patients with benign prostatic hyperplasia: a meta-analysis of randomized controlled trials.
    Zhu YP; Dai B; Zhang HL; Shi GH; Ye DW
    BMC Urol; 2015 Jun; 15():47. PubMed ID: 26032962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost effectiveness comparison of dutasteride and finasteride in patients with benign prostatic hyperplasia--The Markov model based on data from Montenegro.
    Dabanović V; Kostić M; Janković S
    Vojnosanit Pregl; 2016 Jan; 73(1):26-33. PubMed ID: 26964381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transurethral resection of prostate and the role of pharmacological treatment with dutasteride in decreasing surgical blood loss.
    Pastore AL; Mariani S; Barrese F; Palleschi G; Valentini AM; Pacini L; Petrozza V; Carbone A; Cappa M
    J Endourol; 2013 Jan; 27(1):68-70. PubMed ID: 23030716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of dutasteride and finasteride on BPH-related hospitalization, surgery and prostate cancer diagnosis: a record-linkage analysis.
    Cindolo L; Fanizza C; Romero M; Pirozzi L; Autorino R; Berardinelli F; Schips L
    World J Urol; 2013 Jun; 31(3):665-71. PubMed ID: 23239103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroid 5 α-reductase inhibitors targeting BPH and prostate cancer.
    Schmidt LJ; Tindall DJ
    J Steroid Biochem Mol Biol; 2011 May; 125(1-2):32-8. PubMed ID: 20883781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Real-World Medication Adherence and Durable Clinical Benefit in Medicare Patients Treated with 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia.
    Zhang H; Frendl DM; Wang Z; Olumi AF
    J Urol; 2020 Aug; 204(2):325-331. PubMed ID: 32167867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A large retrospective analysis of acute urinary retention and prostate-related surgery in BPH patients treated with 5-alpha reductase inhibitors: dutasteride versus finasteride.
    Issa MM; Runken MC; Grogg AL; Shah MB
    Am J Manag Care; 2007 Feb; 13 Suppl 1():S10-6. PubMed ID: 17295600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4-year results from the randomized, double-blind Combination of Avodart and Tamsulosin (CombAT) trial.
    Roehrborn CG; Barkin J; Siami P; Tubaro A; Wilson TH; Morrill BB; Gagnier RP
    BJU Int; 2011 Mar; 107(6):946-54. PubMed ID: 21332630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of age-related macular degeneration in men receiving 5α-reductase inhibitors: a population-based cohort study.
    Su YC; Shen CY; Shao SC; Lai CC; Hsu SM; Lee CN; Liu CJ; Hung JH; Lai EC
    Age Ageing; 2024 Jul; 53(7):. PubMed ID: 39046116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5α-Reductase inhibitors increase acute coronary syndrome risk in patients with benign prostate hyperplasia.
    Chou CH; Lin CL; Lin MC; Sung FC; Kao CH
    J Endocrinol Invest; 2015 Jul; 38(7):799-805. PubMed ID: 25778849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sexual dysfunction in subjects treated with inhibitors of 5α-reductase for benign prostatic hyperplasia: a comprehensive review and meta-analysis.
    Corona G; Tirabassi G; Santi D; Maseroli E; Gacci M; Dicuio M; Sforza A; Mannucci E; Maggi M
    Andrology; 2017 Jul; 5(4):671-678. PubMed ID: 28453908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [5ARI and PSA: evidences].
    Morgia G; Urzì D; Russo GI
    Urologia; 2014 Sep; 81 Suppl 24():4-11. PubMed ID: 24803356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Alpha-Reductase Inhibitors and Combination Therapy.
    Füllhase C; Schneider MP
    Urol Clin North Am; 2016 Aug; 43(3):325-36. PubMed ID: 27476125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of dutasteride and finasteride for treating benign prostatic hyperplasia: the Enlarged Prostate International Comparator Study (EPICS).
    Nickel JC; Gilling P; Tammela TL; Morrill B; Wilson TH; Rittmaster RS
    BJU Int; 2011 Aug; 108(3):388-94. PubMed ID: 21631695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.